JP6518595B2 - １−インダンスルファミド誘導体を含む疼痛の治療および／または予防剤 - Google Patents
１−インダンスルファミド誘導体を含む疼痛の治療および／または予防剤 Download PDFInfo
- Publication number
- JP6518595B2 JP6518595B2 JP2015553575A JP2015553575A JP6518595B2 JP 6518595 B2 JP6518595 B2 JP 6518595B2 JP 2015553575 A JP2015553575 A JP 2015553575A JP 2015553575 A JP2015553575 A JP 2015553575A JP 6518595 B2 JP6518595 B2 JP 6518595B2
- Authority
- JP
- Japan
- Prior art keywords
- pain
- mmol
- administration
- dihydro
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013262743 | 2013-12-19 | ||
| JP2013262743 | 2013-12-19 | ||
| PCT/JP2014/083374 WO2015093515A1 (ja) | 2013-12-19 | 2014-12-17 | １－インダンスルファミド誘導体を含む疼痛の治療および／または予防剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2015093515A1 JPWO2015093515A1 (ja) | 2017-03-23 |
| JP6518595B2 true JP6518595B2 (ja) | 2019-05-22 |
Family
ID=53402860
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015553575A Active JP6518595B2 (ja) | 2013-12-19 | 2014-12-17 | １−インダンスルファミド誘導体を含む疼痛の治療および／または予防剤 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9610262B2 (https=) |
| EP (1) | EP3085369B1 (https=) |
| JP (1) | JP6518595B2 (https=) |
| KR (1) | KR102250214B1 (https=) |
| CN (1) | CN105792821B (https=) |
| AU (1) | AU2014367781B2 (https=) |
| BR (1) | BR112016012833B1 (https=) |
| CA (1) | CA2932529C (https=) |
| ES (1) | ES2673876T3 (https=) |
| IL (1) | IL246036B (https=) |
| MX (1) | MX370898B (https=) |
| RU (1) | RU2678571C1 (https=) |
| SG (1) | SG11201604484UA (https=) |
| WO (1) | WO2015093515A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20200132858A (ko) * | 2018-03-20 | 2020-11-25 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 간질 치료제 |
| TW202345782A (zh) * | 2022-04-27 | 2023-12-01 | 日商衛材R&D企管股份有限公司 | 帕金森氏症治療用醫藥組成物 |
| KR102815521B1 (ko) | 2022-11-11 | 2025-06-04 | 덕산에테르씨티 주식회사 | 내화성능 및 강도가 보강된 압력용기 |
| KR102803991B1 (ko) | 2022-11-11 | 2025-05-13 | 덕산에테르씨티 주식회사 | 내화성능 및 강도가 보강된 압력용기 |
| KR102815520B1 (ko) | 2022-11-11 | 2025-06-04 | 덕산에테르씨티 주식회사 | 내화성능 및 강도가 보강된 압력용기 |
| KR102917062B1 (ko) | 2023-11-01 | 2026-02-05 | 덕산에테르씨티 주식회사 | 압력 용기의 숄더부 보호용 커버 |
| KR102917063B1 (ko) | 2023-11-01 | 2026-02-23 | 덕산에테르씨티 주식회사 | 압력 용기의 숄더부 보호용 커버 |
| KR102917061B1 (ko) | 2023-11-01 | 2026-02-05 | 덕산에테르씨티 주식회사 | 압력 용기의 숄더부 보호용 커버 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8716231B2 (en) | 2005-12-19 | 2014-05-06 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
| US20070191452A1 (en) | 2006-02-15 | 2007-08-16 | Smith-Swintosky Virginia L | Use of benzo-heteroaryl sulfamide derivatives for the treatment of pain |
| CL2007002994A1 (es) | 2006-10-19 | 2008-02-08 | Wyeth Corp | Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros. |
| TWI433674B (zh) | 2006-12-28 | 2014-04-11 | Infinity Discovery Inc | 環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類 |
| EP2417101B1 (en) * | 2009-04-09 | 2013-10-23 | Merck Sharp & Dohme B.V. | Indane derivatives |
| TW201217312A (en) | 2010-09-22 | 2012-05-01 | Gruenenthal Gmbh | Substituted benzamide compounds |
| RU2508295C2 (ru) * | 2012-03-22 | 2014-02-27 | Общество с ограниченной ответственностью "Биофармокс" | Синтетические пептиды с ненаркотическим типом анальгетического действия |
| MY169073A (en) * | 2012-06-21 | 2019-02-13 | Eisai R&D Man Co Ltd | Indanesulfamide derivative |
-
2014
- 2014-12-17 AU AU2014367781A patent/AU2014367781B2/en active Active
- 2014-12-17 MX MX2016007370A patent/MX370898B/es active IP Right Grant
- 2014-12-17 CA CA2932529A patent/CA2932529C/en active Active
- 2014-12-17 ES ES14871860.4T patent/ES2673876T3/es active Active
- 2014-12-17 SG SG11201604484UA patent/SG11201604484UA/en unknown
- 2014-12-17 RU RU2016122189A patent/RU2678571C1/ru active
- 2014-12-17 WO PCT/JP2014/083374 patent/WO2015093515A1/ja not_active Ceased
- 2014-12-17 CN CN201480066081.3A patent/CN105792821B/zh active Active
- 2014-12-17 BR BR112016012833-8A patent/BR112016012833B1/pt active IP Right Grant
- 2014-12-17 KR KR1020167014850A patent/KR102250214B1/ko active Active
- 2014-12-17 EP EP14871860.4A patent/EP3085369B1/en active Active
- 2014-12-17 US US15/102,046 patent/US9610262B2/en active Active
- 2014-12-17 JP JP2015553575A patent/JP6518595B2/ja active Active
-
2016
- 2016-06-05 IL IL246036A patent/IL246036B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| IL246036B (en) | 2018-11-29 |
| AU2014367781B2 (en) | 2019-07-04 |
| JPWO2015093515A1 (ja) | 2017-03-23 |
| EP3085369B1 (en) | 2018-04-04 |
| KR102250214B1 (ko) | 2021-05-07 |
| EP3085369A1 (en) | 2016-10-26 |
| US9610262B2 (en) | 2017-04-04 |
| WO2015093515A1 (ja) | 2015-06-25 |
| SG11201604484UA (en) | 2016-07-28 |
| ES2673876T3 (es) | 2018-06-26 |
| EP3085369A4 (en) | 2017-05-10 |
| RU2016122189A (ru) | 2018-01-24 |
| RU2678571C1 (ru) | 2019-01-30 |
| CN105792821A (zh) | 2016-07-20 |
| CA2932529A1 (en) | 2015-06-25 |
| US20160303058A1 (en) | 2016-10-20 |
| IL246036A0 (en) | 2016-07-31 |
| BR112016012833B1 (pt) | 2022-11-16 |
| BR112016012833A2 (https=) | 2017-08-08 |
| AU2014367781A1 (en) | 2016-06-23 |
| CA2932529C (en) | 2022-03-22 |
| CN105792821B (zh) | 2018-05-04 |
| MX370898B (es) | 2020-01-09 |
| KR20160106053A (ko) | 2016-09-09 |
| MX2016007370A (es) | 2016-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6518595B2 (ja) | １−インダンスルファミド誘導体を含む疼痛の治療および／または予防剤 | |
| AU2021215274B2 (en) | Targeted drug rescue with novel compositions, combinations, and methods thereof | |
| TWI224102B (en) | Serotonergic agents | |
| KR20190042056A (ko) | 조성물 및 그의 방법 | |
| US20200261442A1 (en) | Targeted drug rescue with novel compositions, combinations, and methods thereof | |
| US20200069674A1 (en) | Targeted drug rescue with novel compositions, combinations, and methods thereof | |
| WO2023049480A1 (en) | Substituted phenylalkylamines | |
| KR20230174211A (ko) | 물질 사용 장애의 치료를 위한 옥사-이보게인 유사체 | |
| JP2021073171A (ja) | （ｒ）−ジミラセタム（１）と（ｓ）−ジミラセタム（２）を非ラセミ比で含む相乗的組成物 | |
| CN103002893B (zh) | 神经障碍性疼痛的治疗药或预防药 | |
| EP3720445A1 (en) | Beta-2 selective adrenergic receptor agonists | |
| WO2018213258A1 (en) | Treatment of merlin-deficient tumors using nae inhibitors | |
| TW200534848A (en) | 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of movement disorders | |
| JP6885560B2 (ja) | モルヒナン誘導体及びその医薬用途 | |
| WO2016099394A1 (en) | Novel selective delta-opioid receptor agonists useful for the treatment of pain, anxiety and depression. | |
| CN118695858A (zh) | 用于预防或治疗精神障碍的药物组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20171117 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180821 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20190108 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190227 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190313 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20190313 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20190409 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190422 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6518595 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |